These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6804061)

  • 21. Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.
    Warrell RP; Coonley CJ; Gee TS
    J Clin Oncol; 1985 May; 3(5):617-21. PubMed ID: 3889229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive therapy of central nervous system leukemia in children: results of CNS-prophylaxis with intrathecal methotrexate and hydrocortisone (author's transl)].
    Fujimoto T; Goya N; Hiyoshi Y; Yokoyama T; Ito M
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):183-9. PubMed ID: 578065
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antitumor activities and mechanisms of action of harringtonine and homoharringtonine].
    Kato T; Takamoto S; Mizutani M; Hato M; Ota K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2393-9. PubMed ID: 6497398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semisynthetic deoxyharringtonine for treating leukemia in mice and humans.
    Cao LX; Huang HP; Cao CP
    Int J Cell Cloning; 1984 Sep; 2(5):327-33. PubMed ID: 6491394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harringtonine in treatment of polycythemia vera.
    Lu LH; Lin SP; Liang YY; Song TY; Li LY
    Chin Med J (Engl); 1983 Jul; 96(7):533-5. PubMed ID: 6418454
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intrathecal application of antineoplastic agents (author's transl)].
    Kölmel HW
    Nervenarzt; 1978 Dec; 49(12):685-96. PubMed ID: 104184
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preventive therapy of central nervous system leukemia in children. Effects of cranial irradiation plus intrathecal methotrexate and hydrocortisone (author's transl)].
    Fujimoto T; Shin H; Kishida K; Take H; Miyazaki S
    Rinsho Ketsueki; 1977 Feb; 18(2):137-44. PubMed ID: 266090
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
    Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
    Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
    [No Abstract]   [Full Text] [Related]  

  • 29. Long survival in an elderly patient with acute myeloid leukaemia after treatment with harringtonine.
    Sullivan J; Leyden M
    Med J Aust; 1985 Jun; 142(13):693-4. PubMed ID: 3859742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the antineoplastic action and toxicity of partially synthetic harringtonine].
    Ji XJ; Zhang FR; Dong XL
    Yao Xue Xue Bao; 1983 Apr; 18(4):299-302. PubMed ID: 6624475
    [No Abstract]   [Full Text] [Related]  

  • 31. Harringtonine combined with other antileukemic drugs in acute nonlymphoblastic leukemia. Clinical analysis of 25 cases.
    Wang ST; Lou BC
    Chin Med J (Engl); 1988 Aug; 101(8):605-7. PubMed ID: 2466617
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of homoharringtonine.
    Smith CR; Powell RG; Suffness M
    J Clin Oncol; 1986 Aug; 4(8):1283. PubMed ID: 3525773
    [No Abstract]   [Full Text] [Related]  

  • 33. The Kerry Burke case and homoharringtonine.
    Sullivan J; Leyden M
    Med J Aust; 1984 Sep; 141(5):317-8. PubMed ID: 6381973
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acute leukemias in adults. V. The effect of intrathecal cytostatic therapy on leukemic changes in the central nervous system].
    Swencz-Szczepanik K; Pawelski S; Maj S; Królikiewicz H; Kaczyńska D; Koszyk E; Apel D
    Acta Haematol Pol; 1981; 12(3-4):161-9. PubMed ID: 6952736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylactic CNS-leukemia therapy with cyclic intrathecal methotrexate and hydrocortisone injection (author's transl)].
    Taguchi N; Koide R; Tsunematsu Y; Sasaki M; Kinugawa N; Takao A
    Rinsho Ketsueki; 1979 Jun; 20(6):608-15. PubMed ID: 582457
    [No Abstract]   [Full Text] [Related]  

  • 36. [Metabolism of harringtonine (author's transl)].
    Ji XJ; Liu JS; Liu ZM
    Yao Xue Xue Bao; 1979; 14(4):234-40. PubMed ID: 495110
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies on the toxicity of harringtonine and homoharringtonine.
    Yongji Z; Hui Y; Xueying L; Yongxing Z; Wenjun L; Xueli L; Yuying Y
    Chin Med J (Engl); 1979 Mar; 92(3):175-80. PubMed ID: 109256
    [No Abstract]   [Full Text] [Related]  

  • 38. [The cytokinetic effects of harringtonine on leukemia L1210 cells. II. Studies by microscopic photometer (author's transl)].
    Wang YC; Pan ZK; Han R
    Zhonghua Zhong Liu Za Zhi; 1980 Dec; 2(4):247-50. PubMed ID: 7297396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Homoharringtonine on traumatic vitreous proliferation].
    Li JP
    Zhonghua Yan Ke Za Zhi; 1989 Jan; 25(1):27-30. PubMed ID: 2503337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of homoharringtonine and harringtonine in serum by chemical ionization mass spectrometry.
    Roboz J; Greaves J; Jui H; Holland JF
    Biomed Mass Spectrom; 1982 Dec; 9(12):510-4. PubMed ID: 7165786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.